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Abstract 
Fertilization is triggered by changes in intracellular calcium concentration. In mammals, 
these transients in ooplasmic calcium concentration take the form of repetitive spikes, 
so called calcium oscillations (Ca2+-oscillations). These oscillations are important for 
relieve of meiotic arrest and to induce all the other events of oocyte activation. 
Although a surface mediated way of oocyte activation has been proposed, there is now 
substantial evidence to suggest that the sperm cell induces these Ca2+-oscillations by 
introducing a sperm specific phospholipase C, PLCζ, in the ooplasm. Ca2+-oscillations 
are also observed after intracytoplasmic sperm injection (ICSI), a successful technique 
in human assisted reproduction. In the rare cases that no fertilization is observed 
following ICSI, this may be due to a deficiency in PLCζ. However, artificial activating 
the oocytes after ICSI by increasing the calcium concentration can restore fertilization 
rates in these cases and support further development, as evidenced by successful 
pregnancies. Further evaluation of the current protocols for assisted oocyte activation is 
appropriate and investigation of the future application of PLCζ is warranted. 
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Introduction 
 
     Calcium is a universal secondary messenger in 
cells controlling diverse biological processes such 
as proliferation, differentiation, axis formation, 
transcriptional activation and apoptosis (1). It plays 
a major role at fertilization and is thus already 
involved at the very beginning of life. Sperm not 
only delivers its genetic material but also triggers 
rises in intracellular calcium concentration ([Ca2+]i) 
and consequently awakens the oocyte which is 
blocked at the metaphase of the second meiotic 
division (MII arrest). For all species an increase in 
[Ca2+]i is necessary and sufficient for the 
completion of oocyte activation and initiation of 
embryonic development (2,3). In mammalian 
oocytes, a series of spikes  in  [ Ca2+ ] i  or so called   
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Ca2+-oscillations, are triggered upon sperm entry. 
These  Ca2+- oscillations  are needed to relieve MII 
arrest and to provoke all the other events of oocyte 
activation, such as the  cortical  reaction ,  maternal 
mRNA recruitment, pronuclear development and 
mitotic cleavage ( 4). MII arrest is characterized by 
a high level of the cyclinB/cdk1 complex, also 
known as maturation promoting factor (MPF). 
MPF prompts metaphase II and is thought to be 
involved in several central features of cell division, 
such as disassembly of the nucleus, chromosome 
condensation, cytoskeletal rearrangements and 
arrest in transcriptional activity (5).  
     MPF activity in the MII-arrested oocyte is 
regulated by the activity of a cytostatic factor 
(CSF). During MII arrest, CSF indeed prevents the 
destruction of MPF by keeping the anaphase-
promoting complex (APC) inactive (figure 1). 
When active, the latter complex labels cyclin B for 
degradation through the ubiquitin pathway. At 
fertilization, MPF levels must decrease sufficiently 
to enable the oocyte to complete the meiosis and 
initiate oocyte activation (6). 
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     Several theories on how the sperm sparks Ca2+-
oscillations and thus activates the oocyte have been 
proposed. In the surface-mediated model of oocyte 
activation, binding of a sperm protein on a putative 
oocyte receptor would activate PLC which in turn 
would produce inositol 1,4,5 trisphosphate, which 
induces release of Ca2+ from intracellular stores 
and subsequently triggers Ca2+-oscillations in the 
oocyte (2). However, although in echinoderms and 
amphibians there is evidence of involvement of 
such an oocyte PLC, no such evidence has been 
forthcoming for mammals and in general there is a 
lack of evidence showing that a surface protein that 
mediates sperm-oocyte binding is linked with 
intracellular signalling leading to oocyte activation 
(7). A second model in which a soluble sperm 
factor introduced into the ooplasm at gamete 
fusion activates the oocyte was proposed by Dale 
et al, on the basis that microinjection of sea urchin 
sperm extract triggered the cortical reaction in sea 
urchin eggs (8). Subsequently Swann and others 
showed that injection of mammalian sperm 
extracts into eggs and oocytes resulted in a pattern 
of Ca2+ release similar to that seen at fertilization 
and also triggered egg activation (9, 10). 
 
The oocyte activating factor PLCζ 
     The identity of the sperm factor remained 
unknown for some time, but then a sperm specific 
phospholipase C named PLCζ was identified 
which had the expected properties of the oocyte 
activating factor (11). Injection of recombinant 
mouse and human PLCζ RNA into mouse oocytes 
not only evokes Ca2+-oscillations similar to those 
induced by sperm but also promotes subsequent 
embryo development (11,12).  
     A similar response was obtained by 
microinjecting recombinant mouse PLCζ  protein 
into mouse oocytes (13). Immunolocalization 
studies have shown that the pattern of localization 
of PLCζ in sperm of both rodents and humans is in 
the expected location for an oocyte activation 
factor, namely the perinuclear theca (14,15). 
Moreover, sperm from transgenic mice expressing 
short hairpin RNAs targeting PLCζ exhibited 
reduced amounts of PLCζ, and when injected into 
mouse oocytes, induced Ca2+ oscillations that 
ended prematurely (16).  
     PLCζ catalyzes the formation of inositol 
trisphosphate, which triggers the release of Ca2+ 
from intracellular stores and subsequently induces 
the calcium oscillations in the oocyte (2). Calcium 
will activate calmodulin dependent kinase II 
(CaMKII), an enzyme known to be sensitive to the 
frequency of calcium oscillations (17). CaMKII 
directly activates APC and also promotes the 
degradation of CSF (18). 
      As a result, the APC is liberated from its 
repression by CSF and the inhibition of MPF will 
be relieved. APC activation causes a decline in 
MPF activity and the concomitant release from the 
MII arrest (Figure 1).  
     The Ca2+-oscillations prevent the MPF levels to 
return to active levels and bring about successful 
activation (4). 
 
Oocyte activation in human assisted 
reproduction technology 
     Calcium oscillations are also observed after 
intracytoplasmic sperm injection (ICSI), a highly 
successful technique used in human assisted 
reproductive medicine in case of male infertility 
(19). Only in a small percentage of the patients 
failed fertilization is observed after ICSI (20). A 
specific group of patients who often face failed 
fertilization are men with globozoospermia, a rare 
disorder characterized by round-headed, acrosome-
less sperm cells (21). The lack of an acrosome was 
considered to be the cause of infertility in these 
patients (22).  
     The introduction of ICSI led to several 
successful attempts resulting in  pregnancies 
following ICSI with globozoospermia sperm, 
however fertilization rates were low (23). 
Moreover, there have been several reports of 
unsuccessful ICSI attempts in cases of 
globozoospermia (24).  
     This suggests that besides the inability to 
interact with the female gamete due to an abnormal 
acrosome, globozoospermia sperm may have 
additional defects that affect their fertilization 
capability. One study employing the mouse oocyte 
activation test (MOAT) to analyse spermatozoa 
from globozoospermic men indicated that they 
could not successfully activate oocytes (25).  
     Currently the presence of PLCζ in sperm cells is 
under investigation and preliminary data confirm 
that sperm from globozoospermic men contain 
lower amounts of PLCζ as compared to normal 
(26). In addition, also other cases of failed 
fertilization may be explained by defects in the 
PLCζ protein.  
 
Assisted oocyte activation 
     Before considering gamete donation, artificial 
activation of the oocytes may be proposed as an 
option to couples who experienced repeated cycles 
with failed fertilization after ICSI. Mammalian 
oocytes such as murine, rabbit, bovine, rat, porcine 
and also human oocytes can namely be activated 
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just by increasing [Ca2+]i using electrical 
activation, ethanol treatment or Ca2+ ionophore 
challenge (27-32).  
     Interestingly, this technique of artificially 
induced oocyte activation at the time of ICSI or 
assisted oocyte activation (AOA) by using for 
example calcium ionophore to increase [Ca2+]i can 
restore normal fertilization rates in these cases and 
support further development as evidenced by 
successful pregnancies and deliveries reported (33-
35). However, some concerns still exist about the 
use of calcium ionophore as an activating agent in 
human ART (33,35). And although no adverse 
effects of ionomycin on in vitro or in vivo mouse 
embryo development were noticed (36), a negative 
long-term effect of this compound can not be 
excluded at present. In addition, some studies have 
shown that the Ca2+-transients induced during 
oocyte activation may influence the number of 
embryos reaching the blastocyst stage and even 
postnatal development (37,38). Ionomycin induces 
only a single Ca2+ transient in human oocytes (39) 
and no Ca2+-oscillations are triggered after 
exposing mouse oocytes injected with human 
sperm deficient in oocyte activating capacity (40). 
Successful clinical application in the human, 
however, suggests that this does not seem to 
prevent further embryonic development.  
     In attempt to induce calcium changes in more 
physiological way, other techniques have been 
introduced such as a modified ICSI technique (41) 
and recently also strontium was applied 
successfully in a clinical setting (42) . Strontium 
acts like a surrogate of Ca2+ in mouse oocytes and 
causes a series of Ca2+ -oscillations similar to those 
observed at fertilization  (28,43). However, the 
observation that no Ca2+-oscillations were 
triggered in human oocytes treated with strontium  
(12) suggests that other mechanisms than described 
for mouse oocytes are involved (43) and that an 
activation protocol based on strontium should still 
be treated with caution. Interestingly, the discovery 
of the oocyte activating factor PLCζ (11) and the 
observation of PLCζ deficiencies in infertile men 
(26), may lead to the development of a more 
physiological method of triggering oocyte 
activation in case of sperm borne fertilization 
failure after ICSI, for example by co-injecting a 
recombinant PLCζ at the time of ICSI.  
     Unraveling the mechanism of oocyte activation 
and determining the role of calcium in this process 
has resulted in promising applications in human 
ART. However, follow-up of the children born 
after assisted oocyte activation remains necessary, 
whatever protocol is used. 
 
Figure 1: Schematic diagram illustrating the calcium-
induced relief from metaphase II arrest and cell cycle 
resumption. The Ca2+-CaM – CaMKII axis directly and 
thus rapidly activates APC (**) and also promotes the 
degradation of CSF, a process with slower kinetics (*). 
CSF degradation releases the inhibition of APC. 
Activated APC (APC+) promotes the degradation of 
Cyclin B and as a consequence, results in MPF 
deactivation. This culminates in the abolishment of MII 
arrest and resumption of the cell cycle. (With kind 
permission of Leybaert L and Dupont G). 
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